Jung E. Choi

Jung Choi currently serves as an Entrepreneur in Residence at Third Rock Ventures and a Board Member at Marea Therapeutics. In addition, Jung holds various board positions at Annexon Biosciences, California Life Sciences, New York Blood Center, and is an Aspen Institute Health Innovators Fellow. Jung's previous role as Chief Business and Strategy Officer at Global Blood Therapeutics, acquired by Pfizer, followed senior positions at InterMune and Chimerix, while also holding a significant tenure at Gilead Sciences as Head of Corporate Development. Educational credentials include a BA in Human Biology and an MBA from Stanford University.